OPRX

Q: What is the price of OptimizeRx (OPRX) today?

The price of OptimizeRx (OPRX) today is $ 6.56, with return of -21.25% compared to the last year. The price of OptimizeRx (OPRX) started the year trading around $ 12.26 and today it is at $ 6.56. Follow the real-time price chart, the historical price of OptimizeRx (OPRX) and international markets.

Q: When does OptimizeRx (OPRX) pay dividends?

OptimizeRx (OPRX) did not distribute dividends in the last year.

Q: Is OptimizeRx (OPRX) worth it?

Currently, OptimizeRx (OPRX) is priced at $ 6.56, with a P/E of 24.46%, representing a deviation of -526% from its historical average P/E. In the last year, the stock showed a variation of -21.25 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -21.25%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy OptimizeRx (OPRX) stock?

Investing in stocks of OptimizeRx (OPRX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of OptimizeRx (OPRX) yield today?

The yield of OptimizeRx (OPRX) was -10.38% in the last month, -21.25% in the last year and -86.43% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of OptimizeRx (OPRX) today, the total investment would be $ 656.00, based on the current price of $ 6.56.If past performance were to repeat, the return on your investment would be:In 1 year: $ 516.60In 5 years: $ 89.02In 10 years: $ 1,379.31It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

OptimizeRx Corporation

Price

$ 6.56

return (12m)

-21.25%

p/e

24.46

p/bv

0.98

DIVIDEND YIELD

0.00%

OPRX price

OPRX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment OPRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-10.38%

3 months

-47.18%

1 year

-21.25%

2 years

-41.59%

5 years

-86.43%

10 years

110.26%

Fundamentals OPRX

review the fundamentals of OptimizeRx shares

P/E

24.46

Sector: -2.04 Industry: 0.41

P/S (PSR)

1.15

Sector: 1.88 Industry: 2.43

P/BV

0.98

Sector: 2.11 Industry: 2.30

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

2.90%

Sector: -25.47% Industry: -24.33%

ROE

4.00%

Sector: -29.41% Industry: -29.69%

ROIC

17.57%

Sector: -411.21% Industry: -75.87%

NET MARGIN

4.69%

Sector: -28.27% Industry: -30.45%

GROSS MARGIN

67.25%

Sector: 44.66% Industry: 50.55%

OPERATING MARGIN

11.03%

Sector: -23.29% Industry: -26.81%

EV/EBITDA

7.57

Sector: -0.79 Industry: 0.98

EV/EBIT

10.25

Sector: -2.18 Industry: -0.36

PRICE-TO-ASSETS

0.71

Sector: 1.13 Industry: 1.22

BVPS

6.75

Sector: 3.60 Industry: 4.74

EPS

0.27

Sector: -0.89 Industry: -0.81

EQUITY-TO-ASSETS RATIO

0.73

Sector: 0.43 Industry: 0.45

LIABILITIES / ASSETS

0.27

Sector: 0.47 Industry: 0.51

CAGR REVENUE 5 YEARS

12.29%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

68.46%

Sector: - Industry: -

FAIR VALUE OF OptimizeRx ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 6.56

Fair Value

$ 0.00

Upside/Downside Return potential.

-2.38%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals OPRX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	38.09	32.96	86.53%	0.71%	$ 786.02 B	31.66%
ISRG	56.27	8.96	15.92%	0.00%	$ 160.69 B	28.38%
TMO	26.55	3.32	12.52%	0.36%	$ 177.98 B	15.05%
SNY	12.52	1.36	10.86%	4.73%	$ 114.19 B	18.68%
NVS	20.29	6.10	30.04%	4.71%	$ 283.76 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.24	2.27	9.38%	3.25%	$ 111.80 B	13.00%
CVS	50.34	1.18	2.35%	3.80%	$ 89.00 B	0.44%
GSK	14.19	5.07	35.71%	3.10%	$ 108.22 B	17.48%
BSX	35.40	0.00	0.00%	0.00%	$ 102.58 B	14.44%
TMDX	17.70	7.12	40.22%	0.00%	$ 3.37 B	31.43%
HCA	15.86	-38.82	-244.82%	0.61%	$ 107.58 B	8.97%
IDXX	42.16	27.82	65.99%	0.00%	$ 44.67 B	24.62%
RMD	21.66	5.09	23.51%	1.06%	$ 32.19 B	27.53%
DHR	35.51	2.44	6.88%	0.71%	$ 128.33 B	14.71%
INMD	9.00	1.24	13.73%	0.00%	$ 844.20 M	25.32%
PHG	24.55	1.98	8.06%	3.31%	$ 25.47 B	5.07%
FMS	11.18	0.75	6.75%	3.57%	$ 12.62 B	5.02%
SYK	38.64	5.59	14.48%	1.04%	$ 125.41 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

OPRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT OptimizeRx

OptimizeRx Corporation

Average Investor10 user rating

4.0 (0 people)

United States

20 years

Founded: 2006

2009

Time since IPO - 17 years

97

Employees

The Company OptimizeRx Corporation (United States), is listed on Nasdaq with a market value of $ 125.50 Millions, having an equity of $ 128.29 Millions.

With a total of 97 employees, the company is listed in the sector of Health and categorized in industry of Health Technology.

In the last 12 months the Company had a revenue of $ 109.44 Millions, which generated a profit in the amount of $ 5.13 Millions.

As for its main indicators, the Company has a P/E ratio of 24.46, a P/BV ratio of 0.98 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker OPRX.

Market cap

$ 125.50 Millions

Net worth

$ 128.29 Millions

US$ 128,290,000.00

Assets

$ 176.92 Millions

US$ 176,920,000.00

Total Shares Outstanding

19.00 Millions

19,000,000

Average Daily Trading Volume

$ 481.93 Thousand

US$ 481,926.00

Sector

Health

Industry

Health Technology

OPRX

OPRX revenue and profits

Financial Results OPRX

DRAG THE FRAME TO SEE MORE DATA

OPRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 73.49 14,09% (12M)

P/E

50.34

3.80%

ROE

2.35%

P/BV

1.18

CI - Cigna

$ 270.02 --18,53% (12M)

P/E

10.14

2.32%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 35.12 --45,37% (12M)

P/E

-2.36

0.00%

ROE

-33.28%

P/BV

0.79

HUM - Humana

$ 177.83 --31,73% (12M)

P/E

17.08

2.09%

ROE

6.70%

P/BV

1.14

HCA - HCA Healthcare

$ 471.84 36,07% (12M)

P/E

15.86

0.61%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 935.58 27,66% (12M)

P/E

38.09

0.71%

ROE

86.53%

P/BV

32.96

NVS - Novartis

$ 154.03 44,93% (12M)

P/E

20.29

4.71%

ROE

30.04%

P/BV

6.10